Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × poly ICLC × 30 days × Clear all

Sponsor

Conditions

Smoldering Multiple Myeloma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma 1 Anemia, Refractory 1

Interventions

pembrolizumab 10 Cisplatin 7 Radiotherapy 5 Gemcitabine 5 Carboplatin 5 Paclitaxel 4 Human Papillomavirus DNA Tests 4 Fulvestrant 4 Bevacizumab 4 zimberelimab 3 tisotumab vedotin 3 Topotecan 3 Specimen Handling 3 Restraint, Physical 3 Pemetrexed 3 Magnetic Resonance Spectroscopy 3 Colposcopy 3 Brachytherapy 3 spartalizumab 2 lenvatinib 2 Vinorelbine 2 Radiation 2 Platinum 2 Nivolumab 2 Irinotecan 2 IFL protocol 2 Drug Therapy 2 Biopsy 2 1,2-diaminocyclohexaneplatinum II citrate 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡